“…Histotripsy can therefore ablate three-dimensional volumes of any required size and shape by translating the focal zone, as determined by the diffraction pattern of the array, through a predetermined volume. Due to these features, histotripsy is currently being developed for many clinical applications including the treatment of kidney stones (Duryea et al 2011), benign prostatic hyperplasia (Hempel et al 2011, Roberts et al 2014, Schuster et al 2018, deep vein thrombosis (Maxwell et al 2011a, Zhang et al 2015, Goudot et al 2019, Bader et al 2021, congenital heart disease (Xu et al 2010, Owens et al 2011, Miller et al 2013, biofilm ablation (Xu et al 2012, Bigelow et al 2018, Childers et al 2021, and cancer (Vlaisavljevich et al 2013b, 2016b, Brisbane et al 2017, Smolock et al 2018, Longo et al 2019, Schade et al 2019.…”